Immunohistochemistry Market By Product Type (Antibodies {Primary Antibodies, Secondary Antibodies}, Equipment {Slide Staining System, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others}, Reagents {Histological stains, Blocking Sera & Reagents, Chromogenic Substrates, Fixation Reagents, Organic Solvents, Proteolytic Enzymes, Diluents, Others}, Kits), By Application (Cancer Diagnosis, Infectious Disease Diagnosis, Autoimmune Disease Diagnosis, Neurological Disease Diagnosis, Drug Development & Research, Others), By End-user (Academic & Research Institutes, Hospitals & Diagnostic Centers, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles, And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Immunohistochemistry Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Rising Prevalence of Cancer Fuels the Adoption of Immunohistochemistry Techniques in Diagnostics and Treatment

3.2.2. Technological Advancements in Automated Immunohistochemistry Systems Enhance Efficiency and Diagnostic Accuracy

3.2.3. Growing Focus on Biomarker Research Drives Immunohistochemistry Adoption in Precision Medicine and Drug Development

3.3. Key industry pitfalls & challenges

3.3.1. High Costs of Immunohistochemistry Instruments and Reagents Limit Accessibility in Resource-Constrained Settings

3.3.2. Limited Skilled Workforce in Immunohistochemistry Slows Adoption and Impacts Diagnostic Efficiency in Emerging Markets

3.3.3. Regulatory Challenges and Lengthy Approval Processes Hinder Innovation in Immunohistochemistry Technologies

3.4. Market Opportunities

3.4.1. Integration of Artificial Intelligence in Immunohistochemistry Drives Innovation in Precision Diagnostics and Personalized Medicine

3.4.2. Expanding Applications of Immunohistochemistry Beyond Oncology into Neurology and Infectious Disease Diagnostics

3.4.3. Increasing Use of Immunohistochemistry in Veterinary Diagnostics Opens Untapped Markets for Specialized Reagents and Instruments

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Immunohistochemistry Market, By Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Antibodies

4.2.1. Primary Antibodies

4.2.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.2. Secondary Antibodies

4.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Equipment

4.3.1. Slide Staining System

4.3.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.2. Tissue Microarrays

4.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.3. Tissue Processing Systems

4.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.4. Slide Scanners

4.3.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.5. Others

4.3.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Reagents

4.4.1. Histological stains

4.4.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.2. Blocking Sera & Reagents

4.4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.3. Chromogenic Substrates

4.4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.4. Fixation Reagents

4.4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.5. Organic Solvents

4.4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.6. Proteolytic Enzymes

4.4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.7. Diluents

4.4.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.8. Others

4.4.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Kits

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Immunohistochemistry Market, Application Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, Application, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Cancer Diagnosis

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Infectious Disease Diagnosis

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Autoimmune Disease Diagnosis

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Neurological Disease Diagnosis

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Drug Development & Research

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.7. Others

5.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Immunohistochemistry Market, End-user Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By End-user, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Academic and Research Institutes

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Hospitals & Diagnostic Centers

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Other

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Immunohistochemistry Market, Region Segment Analysis

7.1. Overview

7.1.1. Global Market Revenue Share, By Region, 2025 & 2035

7.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

7.2. North America

7.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

7.2.2. North America Market Revenue, By Product Type, 2025-2035

7.2.3. North America Market Revenue, By Application, 2025-2035

7.2.4. North America Market Revenue, By End-user, 2025-2035

7.2.5. The U.S.

7.2.5.1. U.S. Market Revenue, By Product Type, 2025-2035

7.2.5.2. U.S. Market Revenue, By Application, 2025-2035

7.2.5.3. U.S. Market Revenue, By End-user, 2025-2035

7.2.6. Canada

7.2.6.1. Canada Market Revenue, By Product Type, 2025-2035

7.2.6.2. Canada Market Revenue, By Application, 2025-2035

7.2.6.3. Canada Market Revenue, By End-user, 2025-2035

7.3. Europe

7.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

7.3.2. Europe Market Revenue, By Product Type, 2025-2035

7.3.3. Europe Market Revenue, By Application, 2025-2035

7.3.4. Europe Market Revenue, By End-user, 2025-2035

7.3.5. Germany

7.3.5.1. Germany Market Revenue, By Product Type, 2025-2035

7.3.5.2. Germany Market Revenue, By Application, 2025-2035

7.3.5.3. Germany Market Revenue, By End-user, 2025-2035

7.3.6. France

7.3.6.1. France Market Revenue, By Product Type, 2025-2035

7.3.6.2. France Market Revenue, By Application, 2025-2035

7.3.6.3. France Market Revenue, By End-user, 2025-2035

7.3.7. U.K.

7.3.7.1. U.K. Market Revenue, By Product Type, 2025-2035

7.3.7.2. U.K. Market Revenue, By Application, 2025-2035

7.3.7.3. U.K. Market Revenue, By End-user, 2025-2035

7.3.8. Italy

7.3.8.1. Italy Market Revenue, By Product Type, 2025-2035

7.3.8.2. Italy Market Revenue, By Application, 2025-2035

7.3.8.3. Italy Market Revenue, By End-user, 2025-2035

7.3.9. Spain

7.3.9.1. Spain Market Revenue, By Product Type, 2025-2035

7.3.9.2. Spain Market Revenue, By Application, 2025-2035

7.3.9.3. Spain Market Revenue, By End-user, 2025-2035

7.3.10. Rest of Europe

7.3.10.1. Rest of Europe Market Revenue, By Product Type, 2025-2035

7.3.10.2. Rest of Europe Market Revenue, By Application, 2025-2035

7.3.10.3. Rest of Europe Market Revenue, By End-user, 2025-2035

7.4. Asia Pacific

7.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

7.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035

7.4.3. Asia Pacific Market Revenue, By Application, 2025-2035

7.4.4. Asia Pacific Market Revenue, By End-user, 2025-2035

7.4.5. China

7.4.5.1. China Market Revenue, By Product Type, 2025-2035

7.4.5.2. China Market Revenue, By Application, 2025-2035

7.4.5.3. China Market Revenue, By End-user, 2025-2035

7.4.6. Japan

7.4.6.1. Japan Market Revenue, By Product Type, 2025-2035

7.4.6.2. Japan Market Revenue, By Application, 2025-2035

7.4.6.3. Japan Market Revenue, By End-user, 2025-2035

7.4.7. India

7.4.7.1. India Market Revenue, By Product Type, 2025-2035

7.4.7.2. India Market Revenue, By Application, 2025-2035

7.4.7.3. India Market Revenue, By End-user, 2025-2035

7.4.8. Australia

7.4.8.1. Australia Market Revenue, By Product Type, 2025-2035

7.4.8.2. Australia Market Revenue, By Application, 2025-2035

7.4.8.3. Australia Market Revenue, By End-user, 2025-2035

7.4.9. South Korea

7.4.9.1. South Korea Market Revenue, By Product Type, 2025-2035

7.4.9.2. South Korea Market Revenue, By Application, 2025-2035

7.4.9.3. South Korea Market Revenue, By End-user, 2025-2035

7.4.10. Singapore

7.4.10.1. Singapore Market Revenue, By Product Type, 2025-2035

7.4.10.2. Singapore Market Revenue, By Application, 2025-2035

7.4.10.3. Singapore Market Revenue, By End-user, 2025-2035

7.4.11. Rest of Asia Pacific

7.4.11.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035

7.4.11.2. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

7.4.11.3. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

7.5. Latin America

7.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

7.5.2. Latin America Market Revenue, By Product Type, 2025-2035

7.5.3. Latin America Market Revenue, By Application, 2025-2035

7.5.4. Latin America Market Revenue, By End-user, 2025-2035

7.5.5. Brazil

7.5.5.1. Brazil Market Revenue, By Product Type, 2025-2035

7.5.5.2. Brazil Market Revenue, By Application, 2025-2035

7.5.5.3. Brazil Market Revenue, By End-user, 2025-2035

7.5.6. Argentina

7.5.6.1. Argentina Market Revenue, By Product Type, 2025-2035

7.5.6.2. Argentina Market Revenue, By Application, 2025-2035

7.5.6.3. Argentina Market Revenue, By End-user, 2025-2035

7.5.7. Mexico

7.5.7.1. Mexico Market Revenue, By Product Type, 2025-2035

7.5.7.2. Mexico Market Revenue, By Application, 2025-2035

7.5.7.3. Mexico Market Revenue, By End-user, 2025-2035

7.5.8. Rest of Latin America

7.5.8.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035

7.5.8.2. Rest of Latin America Market Revenue, By Application, 2025-2035

7.5.8.3. Rest of Latin America Market Revenue, By End-user, 2025-2035

7.6. MEA

7.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

7.6.2. MEA Market Revenue, By Product Type, 2025-2035

7.6.3. MEA Market Revenue, By Application, 2025-2035

7.6.4. MEA Market Revenue, By End-user, 2025-2035

7.6.5. GCC Countries

7.6.5.1. GCC Countries Market Revenue, By Product Type, 2025-2035

7.6.5.2. GCC Countries Market Revenue, By Application, 2025-2035

7.6.5.3. GCC Countries Market Revenue, By End-user, 2025-2035

7.6.6. South Africa

7.6.6.1. South Africa Market Revenue, By Product Type, 2025-2035

7.6.6.2. South Africa Market Revenue, By Application, 2025-2035

7.6.6.3. South Africa Market Revenue, By End-user, 2025-2035

7.6.7. Rest of Middle-East & Africa

7.6.7.1. Rest of Middle-East & Africa Market Revenue, By Product Type, 2025-2035

7.6.7.2. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

7.6.7.3. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

8. Company Profile

8.1. F. Hoffmann-La Roche Ltd.

8.1.1. Business Overview

8.1.2. Financial Performance

8.1.3. Product/Service Offerings

8.1.4. Strategies & recent developments

8.1.5. SWOT Analysis

8.2. Agilent Technologies Inc.

8.2.1. Business Overview

8.2.2. Financial Performance

8.2.3. Product/Service Offerings

8.2.4. Strategies & recent developments

8.2.5. SWOT Analysis

8.3. Danaher Corporation

8.3.1. Business Overview

8.3.2. Financial Performance

8.3.3. Product/Service Offerings

8.3.4. Strategies & recent developments

8.3.5. SWOT Analysis

8.4. Thermo Fisher Scientific Inc.

8.4.1. Business Overview

8.4.2. Financial Performance

8.4.3. Product/Service Offerings

8.4.4. Strategies & recent developments

8.4.5. SWOT Analysis

8.5. Bio-Rad Laboratories Inc.

8.5.1. Business Overview

8.5.2. Financial Performance

8.5.3. Product/Service Offerings

8.5.4. Strategies & recent developments

8.5.5. SWOT Analysis

8.6. Abbott Laboratories

8.6.1. Business Overview

8.6.2. Financial Performance

8.6.3. Product/Service Offerings

8.6.4. Strategies & recent developments

8.6.5. SWOT Analysis

8.7. Merck KGaA

8.7.1. Business Overview

8.7.2. Financial Performance

8.7.3. Product/Service Offerings

8.7.4. Strategies & recent developments

8.7.5. SWOT Analysis

8.8. PerkinElmer, Inc.

8.8.1. Business Overview

8.8.2. Financial Performance

8.8.3. Product/Service Offerings

8.8.4. Strategies & recent developments

8.8.5. SWOT Analysis

8.9. Cell Signaling Technology Inc.

8.9.1. Business Overview

8.9.2. Financial Performance

8.9.3. Product/Service Offerings

8.9.4. Strategies & recent developments

8.9.5. SWOT Analysis

8.10. Biocare Medical, LLC

8.10.1. Business Overview

8.10.2. Financial Performance

8.10.3. Product/Service Offerings

8.10.4. Strategies & recent developments

8.10.5. SWOT Analysis

8.11. Abcam Plc

8.11.1. Business Overview

8.11.2. Financial Performance

8.11.3. Product/Service Offerings

8.11.4. Strategies & recent developments

8.11.5. SWOT Analysis

8.12. Sakura Finetek Inc.

8.12.1. Business Overview

8.12.2. Financial Performance

8.12.3. Product/Service Offerings

8.12.4. Strategies & recent developments

8.12.5. SWOT Analysis

8.13. Siemens Healthineers AG

8.13.1. Business Overview

8.13.2. Financial Performance

8.13.3. Product/Service Offerings

8.13.4. Strategies & recent developments

8.13.5. SWOT Analysis

8.14. Eli Lilly and Company

8.14.1. Business Overview

8.14.2. Financial Performance

8.14.3. Product/Service Offerings

8.14.4. Strategies & recent developments

8.14.5. SWOT Analysis

8.15. Leica Biosystems

8.15.1. Business Overview

8.15.2. Financial Performance

8.15.3. Product/Service Offerings

8.15.4. Strategies & recent developments

8.15.5. SWOT Analysis

8.16. Promega Corporation

8.16.1. Business Overview

8.16.2. Financial Performance

8.16.3. Product/Service Offerings

8.16.4. Strategies & recent developments

8.16.5. SWOT Analysis

8.17. Becton, Dickinson, and Company

8.17.1. Business Overview

8.17.2. Financial Performance

8.17.3. Product/Service Offerings

8.17.4. Strategies & recent developments

8.17.5. SWOT Analysis

8.18. OriGene Technologies Inc.

8.18.1. Business Overview

8.18.2. Financial Performance

8.18.3. Product/Service Offerings

8.18.4. Strategies & recent developments

8.18.5. SWOT Analysis

8.19. Bio-Techne

8.19.1. Business Overview

8.19.2. Financial Performance

8.19.3. Product/Service Offerings

8.19.4. Strategies & recent developments

8.19.5. SWOT Analysis

8.20. GenScript

8.20.1. Business Overview

8.20.2. Financial Performance

8.20.3. Product/Service Offerings

8.20.4. Strategies & recent developments

8.20.5. SWOT Analysis